Amiotrófiás laterálszklerózis (ALS): vizsgálatok itt: Belgium
14 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 13.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleStudy is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
- Where
- Leuven
- Életkor
- 18 év and over
- People
- 36 worldwide
- Run by
- Vector Y Therapeutics
See details and how to joinNCT07287397 · EU 2025-522697-37-00 - 1. fázisTaking peopleA Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
- Where
- Leuven
- Életkor
- 18 év to 75 év
- People
- 36 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07100119 · EU 2025-521295-60-00 - 3. fázisTaking peoplePridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
- Where
- Leuven
- Életkor
- 18 év to 80 év
- People
- 500 worldwide
- Run by
- Prilenia
See details and how to joinNCT07322003 - 1. fázisTaking peopleA Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
- Where
- Leuven
- Életkor
- 18 év to 80 év
- People
- 32 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07571174 - 1. fázisTaking peopleA Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral Sclerosis (ALS)
- Where
- Leuven
- Életkor
- 18 év to 80 év
- People
- 32 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07571200 · EU 2026-525574-19-00 - 1/2. fázisTaking peopleFirst in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
- Where
- Leuven
- Életkor
- 18 év and over
- People
- 54 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06351592 · EU 2023-510344-20-00 - 2. fázisTaking peopleUsnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
- Where
- Leuven
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- Zydus Therapeutics Inc.
See details and how to joinNCT07023835 · EU 2025-522580-15-00 - No phaseCsak meghívásosComparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.
- Where
- Leuven
- Életkor
- 28 nap and over
- People
- 1600
- Run by
- prof. dr. Koen Van Laere
See details and how to joinNCT07595666 - 3. fázisTaking peoplePridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS (PREVAiLS)
- Where
- Leuven
- Életkor
- 18 év and over
- People
- 420 worldwide
- Run by
- Ferrer Internacional S.A.
See details and how to join2025-524002-16-00 - No phaseTaking peopleUltra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
- Where
- Leuven
- Életkor
- 18 év to 90 év
- People
- 300
- Run by
- Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT07509125 - 1. fázisTaking peopleQuantification of Hsp90 in the Human Brain
- Where
- Leuven
- Életkor
- 18 év to 70 év
- People
- 48
- Run by
- Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT07380204 · EU 2023-510532-36-00 - No phaseTaking peopleContinuous Measurement of Activity in Patients With Muscle Pathology and in Control Subjects. ActiSLA Part.
- Where
- Liège
- Életkor
- 18 év and over
- People
- 45
- Run by
- Centre Hospitalier Universitaire de Liege
See details and how to joinNCT04882904 - 3. fázisTaking peopleEfficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- Where
- Leuven
- Életkor
- 18 év to 81 év
- People
- 495 worldwide
- Run by
- AB Science
See details and how to joinNCT03127267 - No phaseTaking peopleHolter of Movement in Patients With Amyotrophic Lateral Sclerosis.
- Where
- Leuven, Liège
- Életkor
- 18 év and over
- People
- 30 worldwide
- Run by
- Centre Hospitalier Universitaire de Liege
See details and how to joinNCT06228001